Actively Recruiting
Clinical and Instrumental Assessment Tools for Neurogenic Dysphagia: Translation and Validation
Led by IRCCS San Camillo, Venezia, Italy · Updated on 2026-04-24
100
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the Italian translation and validation of several clinical tools designed to assess swallowing and oral-motor function in patients with neurogenic dysphagia. These tools include the New Zealand Secretion Severity Scale for secretion management, the Reflex Cough Test from the cranial nerves assessment, the VASES scale used during fiberoptic endoscopic evaluation of swallowing, and the Drooling Severity Scale for saliva control. The study aims to provide reliable and standardized assessment instruments in Italian to help clinicians caring for people with neurological swallowing difficulties. The study involves no active treatment but focuses on validating these assessment tools in about 100 adult patients diagnosed with neurogenic dysphagia caused by various neurological conditions. Participants will undergo evaluations using the translated scales to test their internal consistency and inter-rater reliability. This observational study does not involve experimental interventions but uses diagnostic tests to collect data. Participants will be assessed once at baseline, with researchers measuring the consistency and reliability of the secretion and drooling scales as primary and secondary outcomes. The study includes clinical evaluations of swallowing and reflex cough function, with all assessments performed under stable medical conditions. The total duration of participation and follow-up is not specified, but the focus is on one-time validation measurements to support future clinical use of these tools.
CONDITIONS
Brief Title
Clinical and Instrumental Assessment Tools for Neurogenic Dysphagia: Translation and Validation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients 18 years or older
- Diagnosed with neurogenic dysphagia due to any neurological condition such as stroke, Parkinson's disease, multiple sclerosis, or traumatic brain injury
- Able to understand and comply with study procedures
- Provide written informed consent or legal representative consent if necessary
- Stable medical and neurological condition at the time of assessment
You will not qualify if you...
- Active respiratory infection or acute illness affecting swallowing at the time of assessment
- History of head and neck surgery or anatomical abnormalities preventing standardized assessment of swallowing or reflex cough
- Severe uncontrolled cardiac, pulmonary, or systemic conditions that make participation unsafe
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 1 day
Participants undergo clinical and instrumental assessments to evaluate neurogenic dysphagia using validated tools.
1 visit (in-person)
Trial Site Locations
Total: 1 location
1
IRCCS San Camillo
Venezia, Italy, Italy, 30126
Actively Recruiting
Research Team
S
Sara Nordio
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here